Healios KK (HLOSF)
0.965
-0.03
(-2.86%)
USD |
OTCM |
May 17, 09:30
Healios Cash from Operations (Quarterly): -4.144M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.144M |
| December 31, 2023 | -8.04M |
| September 30, 2023 | -3.584M |
| June 30, 2023 | -3.357M |
| March 31, 2023 | -5.133M |
| December 31, 2022 | -7.190M |
| September 30, 2022 | -8.275M |
| June 30, 2022 | -8.069M |
| March 31, 2022 | -11.75M |
| December 31, 2021 | -16.59M |
| September 30, 2021 | -9.884M |
| Date | Value |
|---|---|
| June 30, 2021 | -7.538M |
| March 31, 2021 | -12.37M |
| December 31, 2020 | -11.66M |
| September 30, 2020 | -7.931M |
| June 30, 2020 | -9.444M |
| March 31, 2020 | -7.924M |
| December 31, 2019 | -8.446M |
| September 30, 2019 | -11.73M |
| June 30, 2019 | -12.11M |
| March 31, 2019 | -12.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.59M
Minimum
Dec 2021
-3.357M
Maximum
Jun 2023
-8.759M
Average
-8.172M
Median
Cash from Operations (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.999B |
| Nxera Pharma Co Ltd | -14.86M |
| PeptiDream Inc | -12.96M |
| AnGes Inc | -- |
| SanBio Co Ltd | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.480M |
| Cash from Financing (Quarterly) | 14.90M |
| Free Cash Flow | -19.34M |
| Free Cash Flow Per Share (Quarterly) | -0.0501 |
| Free Cash Flow to Equity (Quarterly) | -2.163M |
| Free Cash Flow to Firm (Quarterly) | 5.316M |
| Free Cash Flow Yield | -27.48% |